1994
DOI: 10.1016/0959-8049(94)90750-1
|View full text |Cite
|
Sign up to set email alerts
|

A survey of the management of breast cancer in England and Wales

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…The failure to deliver adjuvant chemotherapy to pre-menopausal node-positive women, which the overview of adjuvant chemotherapy shows to have a survival advantage, is similarly disadvantaging women (Early Breast Trialists Collaborative Group, 1992). This and the survey of Harries et al (1996) reinforce the view that patients should be seen in multidisciplinary teams of surgeons, radiologists, pathologists and oncologists for an initial decision on management once the diagnosis has been established.…”
Section: G U E S T E D I T O R I a Lmentioning
confidence: 58%
See 2 more Smart Citations
“…The failure to deliver adjuvant chemotherapy to pre-menopausal node-positive women, which the overview of adjuvant chemotherapy shows to have a survival advantage, is similarly disadvantaging women (Early Breast Trialists Collaborative Group, 1992). This and the survey of Harries et al (1996) reinforce the view that patients should be seen in multidisciplinary teams of surgeons, radiologists, pathologists and oncologists for an initial decision on management once the diagnosis has been established.…”
Section: G U E S T E D I T O R I a Lmentioning
confidence: 58%
“…In breast cancer, the commonest malignancy affecting women in the UK, consensus management is much less frequently practised despite the availability of widely publicized guidelines on management. Harries et al (1996) have conducted the largest survey of the management of breast cancer in England and Wales. This was a questionnaire survey carried out in 1992 covering the advice the surgeon would offer on diagnosis, management of the primary tumour, the axilla, the elderly, treatment of recurrence, and frequency of, and investigations during, follow-up.…”
Section: G U E S T E D I T O R I a Lmentioning
confidence: 99%
See 1 more Smart Citation
“…Trials rarely include more than a small fraction of patients with a given cancer, and incorporation of the results into routine clinical practice can be slow, either because of delay in acceptance or lack of equipment or resources [21]. Trials often exclude elderly patients [22], even though opinion varies widely on how to treat breast cancer, both for elderly women [23] and for those under 50 years old [24], and older patients are less likely to be referred for specialist advice [25]. For all these reasons, cancer survival among patients recruited in clinical trials is inevitably higher than the average for all cancer patients.…”
Section: Full Textmentioning
confidence: 99%
“…Treatment protocols for breast cancer vary widely, and adherence to guidelines in the UK appears poor [23,32,42]. The UK boasts fewer oncologists per head of population than most comparable European countries [43], and there is some evidence that breast cancer survival depends on access to a specialist [44].…”
Section: Full Textmentioning
confidence: 99%